X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (259) 259
humans (183) 183
male (156) 156
cholesterol (153) 153
female (132) 132
animals (128) 128
mice (100) 100
cholesterol - metabolism (98) 98
biochemistry & molecular biology (92) 92
middle aged (76) 76
cholesterol - blood (73) 73
aged (69) 69
lipids (67) 67
phytosterols (66) 66
adult (63) 63
atherosclerosis (59) 59
metabolism (55) 55
brain - metabolism (53) 53
brain (48) 48
plant sterols (46) 46
mice, inbred c57bl (45) 45
mice, knockout (44) 44
sterols (42) 42
liver - metabolism (41) 41
neurosciences (40) 40
physiological aspects (36) 36
phytosterols - blood (36) 36
analysis (35) 35
oxysterols (33) 33
diet (32) 32
cholesterol - analogs & derivatives (31) 31
homeostasis (31) 31
plasma (31) 31
alzheimer's disease (29) 29
24s-hydroxycholesterol (28) 28
absorption (28) 28
risk factors (28) 28
alzheimers-disease (26) 26
apolipoproteins e - genetics (26) 26
disease models, animal (26) 26
hydroxycholesterols - blood (26) 26
lipoproteins (26) 26
rodents (26) 26
atp-binding cassette transporters - genetics (25) 25
biomarkers - blood (25) 25
cholesterol - biosynthesis (25) 25
dietary-cholesterol (25) 25
abridged index medicus (24) 24
aged, 80 and over (24) 24
article (24) 24
cardiac & cardiovascular systems (24) 24
cell biology (24) 24
inflammation (24) 24
liver (24) 24
mice, transgenic (24) 24
multidisciplinary sciences (23) 23
nutrition & dietetics (23) 23
phytosterols - metabolism (23) 23
disease (22) 22
pharmacology & pharmacy (22) 22
alzheimer disease - genetics (21) 21
hydroxycholesterols - metabolism (21) 21
research (21) 21
sitosterols - blood (21) 21
expression (20) 20
lathosterol (20) 20
lipid metabolism (20) 20
macrophages (20) 20
sitosterol (20) 20
time factors (20) 20
apolipoprotein e (19) 19
cholesterol absorption (19) 19
cholesterol homeostasis (19) 19
hypercholesterolemia (19) 19
nutrition (19) 19
peripheral vascular disease (19) 19
sitosterolemia (19) 19
anticholesteremic agents (18) 18
bile (18) 18
cardiovascular (18) 18
double-blind method (18) 18
endocrinology & metabolism (18) 18
neurology (18) 18
research article (18) 18
adolescent (17) 17
apolipoproteins (17) 17
cells, cultured (17) 17
central-nervous-system (17) 17
cholesterol synthesis (17) 17
cholesterol, ldl - blood (17) 17
coronary-heart-disease (17) 17
in-vitro (17) 17
risk (17) 17
alzheimer disease - metabolism (16) 16
amyloid precursor protein (16) 16
apolipoprotein-e (16) 16
biophysics (16) 16
case-control studies (16) 16
cholesterol metabolism (16) 16
circulation (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 51, Issue 16, pp. 1553 - 1561
Journal Article
Nature Immunology, ISSN 1529-2908, 02/2014, Volume 15, Issue 2, pp. 152 - 160
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 3, pp. 325 - 326
  (4) observed rapid atheroma progression in hyporesponders to statin therapy, and the PRECISE-IVUS study (Plaque Regression With Cholesterol Absorption... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Anticholesteremic agents | Cardiovascular agents | Cardiovascular disease | Lipids | Acute coronary syndromes | Low density lipoprotein | Statins | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, pp. e0146326 - e0146326
Background Toll-like receptors (TLR) of the innate immune system have been closely linked with the development of atherosclerotic lesions. TLR9 is activated by... 
SYSTEMIC INFLAMMATION | ACTIVATION | DENDRITIC CELLS | CHOLESTEROL | DNA | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | TLR9 | CARDIAC DYSFUNCTION | OLIGODEOXYNUCLEOTIDE | INNATE IMMUNITY | Carotid Arteries - metabolism | Immunohistochemistry | Body Weight | Reactive Oxygen Species - metabolism | Atherosclerosis - genetics | Humans | DNA, Single-Stranded - genetics | Inflammation - metabolism | Flow Cytometry | Oligodeoxyribonucleotides - genetics | Cell-Derived Microparticles - metabolism | Disease Models, Animal | Cytokines - metabolism | Atherosclerosis - physiopathology | Mice, Inbred C57BL | Cells, Cultured | Vascular Diseases - genetics | Mice, Transgenic | Atherosclerosis - metabolism | Aorta - pathology | Regeneration | Animals | Spleen - metabolism | Endothelium, Vascular - metabolism | Apolipoproteins E - genetics | Mice | Oligodeoxyribonucleotides - pharmacology | Toll-Like Receptor 9 - metabolism | Vascular Diseases - metabolism | Complications and side effects | Care and treatment | Cytokines | Patient outcomes | Atherosclerosis | Development and progression | Research | Apolipoproteins | Reactive oxygen species | Oligonucleotides | Smooth muscle | Stimulation | Carotid arteries | Microparticles | Proteins | Signal transduction | Receptors | Vascular diseases | Apolipoprotein E | Rodents | Denudation | Toll-like receptors | Aorta | Lesions | Vascular endothelial growth factor receptor 2 | Deoxyribonucleic acid--DNA | Immune system | CpG islands | Inflammation | Nucleic acids | Cholesterol | TLR9 protein | Immune systems | Arteriosclerosis | Ligands | Apoptosis | Veins & arteries | Index Medicus | Deoxyribonucleic acid
Journal Article
PLoS ONE, ISSN 1932-6203, 2012, Volume 7, Issue 3, pp. e34378 - 7 p.
Non-alcoholic steatohepatitis (NASH) is characterized by steatosis and inflammation, which can further progress into fibrosis and cirrhosis. Recently, we... 
LDL | SCAVENGER RECEPTOR CD36 | MULTIDISCIPLINARY SCIENCES | DISEASE | ATHEROSCLEROSIS | ACCUMULATION | PROTECTS | Inflammation - pathology | Kupffer Cells - pathology | CD36 Antigens - deficiency | Liver - pathology | CD36 Antigens - genetics | Fatty Liver - pathology | Lipids - chemistry | Lysosomes - metabolism | CD36 Antigens - metabolism | Bone Marrow Transplantation | Non-alcoholic Fatty Liver Disease | Receptors, LDL - deficiency | Female | Scavenger Receptors, Class A - genetics | Kupffer Cells - metabolism | Receptors, LDL - genetics | Fatty Liver - metabolism | Liver - metabolism | Scavenger Receptors, Class A - deficiency | Receptors, LDL - metabolism | Lipid Metabolism | Cholesterol - metabolism | Mice, Knockout | Animals | Mice | Scavenger Receptors, Class A - metabolism | Lipids | Inflammation | Macrophages | Liver cirrhosis | Cholesterol | Syngeneic grafts | Trafficking | Liver | Kupffer cells | Bone marrow transplantation | Acidification | Homeostasis | Inflammatory response | Biology | Autophagy | Accumulation | Liver cancer | Signal transduction | Receptors | Toxicology | Clonal deletion | Rodents | Atherosclerosis | Deletion | Bone marrow | Scavenger receptors | Lipoprotein (low density) receptors | Liver diseases | CD36 antigen | Steatosis | Nutrition research | Pathology | Cirrhosis | Lipoproteins | Microscopy | Internalization | Fibrosis | Intracellular | Laboratory animals | Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2012, Volume 7, Issue 1, pp. e30668 - 11 p.
Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammation, which can progress into fibrosis and cirrhosis. Exploring the molecular... 
SCAVENGER RECEPTOR | IN-VIVO | BIOLOGY | LOW-DENSITY-LIPOPROTEIN | ANIMAL-MODELS | ATHEROSCLEROSIS | STEATOHEPATITIS | DEFICIENT MICE | HEPATIC STEATOSIS | MOUSE MODELS | APOLIPOPROTEIN-E | Liver - pathology | Fatty Liver - pathology | Cholesterol - blood | Humans | Fatty Liver - complications | Diet, High-Fat - adverse effects | Apoptosis - genetics | Male | Inflammation - complications | Time Factors | Non-alcoholic Fatty Liver Disease | Receptors, LDL - deficiency | Lipoproteins, LDL - metabolism | Hyperlipidemias - complications | Disease Models, Animal | Fatty Liver - genetics | Receptors, LDL - genetics | Kupffer Cells - cytology | Apolipoprotein E2 - genetics | Bone Marrow Cells - cytology | Liver Cirrhosis - complications | Liver - metabolism | Mice, Inbred C57BL | Gene Expression Regulation | Cholesterol - metabolism | Gene Knockout Techniques | Gene Knock-In Techniques | Animals | Fatty Liver - immunology | Mice | Medical research | Low density lipoproteins | Physiological aspects | Medicine, Experimental | Inflammation | Liver cirrhosis | Cholesterol | Lipoproteins (low density) | Animal models | Liver | Inflammatory response | Cytotoxicity | Arthritis | Macrophages | Metabolic syndrome | Toxicology | Fatty liver | Rodents | Hydrofluorocarbons | Atherosclerosis | Bone marrow | Genetics | Lipoprotein (low density) receptors | Physiology | Damage | Liver diseases | Cytokines | Apolipoproteins | Low density lipoprotein | Feeding | Steatosis | Nutrition research | Pathology | Cirrhosis | Molecular modelling | Fibrosis | Insulin resistance | Laboratory animals | Binding sites | Apoptosis | Index Medicus
Journal Article
Science, ISSN 0036-8075, 02/2018, Volume 359, Issue 6376, pp. 684 - 688
Journal Article
Lipids, ISSN 0024-4201, 06/2015, Volume 50, Issue 6, pp. 529 - 541
Journal Article
Journal Article
Heart, ISSN 1355-6037, 08/2019, Volume 105, Issue 16, pp. 1291 - 1292
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 11/2014, Volume 55, Issue 11, pp. 2408 - 2415
Reduced plasma LDL-cholesterol is a hallmark of hyperthyroidism and is caused by transcriptional stimulation of LDL receptors in the liver. Here, we... 
Fibroblast growth factor | Fibroblast growth factor 21 | Lipoproteins/metabolism | Cholesterol/absorption | Drug therapy/hypolipidemic drugs | Eprotirome | Proprotein convertase subtilisin/kexin type 9 | Cholesterol 7alpha-hydroxylase | Fibroblast growth factor 19 | Bile acids and salts/biosynthesis | cholesterol 7alpha-hydroxylase | fibroblast growth factor 21 | proprotein convertase subtilisin/kexin type 9 | eprotirome | bile acids and salts/biosynthesis | BIOCHEMISTRY & MOLECULAR BIOLOGY | KEXIN TYPE 9 | A-IV | HMG-COA REDUCTASE | cholesterol/absorption | drug therapy/hypolipidemic drugs | HEPATIC CHOLESTEROL 7-ALPHA-HYDROXYLASE | MESSENGER-RNA LEVELS | HYPOPHYSECTOMIZED RATS | fibroblast growth factor | PLASMA | SERUM LEVELS | DIURNAL-VARIATION | lipoproteins/metabolism | GROWTH-FACTOR 21 | fibroblast growth factor 19 | Bile Acids and Salts - blood | Cholesterol - blood | Humans | Middle Aged | Bile Acids and Salts - chemistry | Intestinal Absorption - drug effects | Hyperthyroidism - metabolism | Male | Apolipoproteins B - blood | Insulin - blood | Young Adult | Liver - drug effects | Body Composition - drug effects | Adult | Female | Proprotein Convertases - blood | Lipoprotein(a) - blood | Hyperthyroidism - enzymology | Bile Acids and Salts - biosynthesis | Hyperthyroidism - blood | Liver - metabolism | Receptors, Thyroid Hormone - agonists | Fibroblast Growth Factor 9 - blood | Fibroblast Growth Factors - blood | Thyroid Hormones - metabolism | Serine Endopeptidases - blood | Adolescent | Anilides - pharmacology | Aged | Blood Glucose - metabolism | Proprotein Convertase 9 | Index Medicus | kexin type 9 | Patient-Oriented and Epidemiological Research | proprotein convertase subtilisin | drug therapy | absorption | hypolipidemic drugs | biosynthesis | bile acids and salts | cholesterol | metabolism | lipoproteins
Journal Article